Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $33.4450 (0.21%) ($33.1950 - $33.4450) on Wed. May. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.33% (three month average) | RSI | 56 | Latest Price | $33.4450(0.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.6% a day on average for past five trading days. | Weekly Trend | HALO advances 2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(38%) IWO(37%) XBI(35%) IWM(34%) IBB(32%) | Factors Impacting HALO price | HALO will decline at least -1.665% in a week (0% probabilities). UUP(-16%) TBT(-12%) VXX(-8%) IPO(-5%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.665% (StdDev 3.33%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $33.36(0.25%) | 10 Day Moving Average | $32.45(3.07%) | 20 Day Moving Average | $32.64(2.47%) | To recent high | -33.6% | To recent low | 10.9% | Market Cap | $4.571b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |